Concepedia

Xiangguo Cui

XC

Statistics

Publications

3

Citations

57

H-Index

3

Active since

2023

Affiliations

China Medical University(Current)

First Hospital of China Medical University

Xiangguo Cui is an author at China Medical University specializing in microrna in cancer, apoptosis in cancer, and phosphatidylinositol 3-kinase-akt pathway.

Publications per year

2023–2024

3

Publications

3

microRNA-944 inhibits breast cancer cell proliferation and promotes cell apoptosis by reducing SPP1 through inactivating the PI3K/Akt pathway

Ying Zhang, Shan Li, Xiangguo Cui et al. · APOPTOSIS · 2023 · 31 citations

, , +12

Targeting MS4A4A: A novel pathway to improve immunotherapy responses in glioblastoma

Guangcai Shao, Xiangguo Cui, Yiliang Wang et al. · CNS Neuroscience & Therapeutics · 2024 · 16 citations · Full text

, , +17

Extracellular vesicles derived from paclitaxel-sensitive nasopharyngeal carcinoma cells deliver miR-183-5p and impart paclitaxel sensitivity through a mechanism involving P-gp

Xiangguo Cui, Yu Chen, Lanqing Zhao et al. · Cell Biology and Toxicology · 2023 · 10 citations

, , +15

1–3 of 3